{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Digestive+Disorders&page=17", "query": { "condition": "Digestive Disorders", "page": 17 }, "page_size": 10 }, "pagination": { "page": 17, "page_size": 10, "total_count": 14925, "total_pages": 1493, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Digestive+Disorders&page=18&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Digestive+Disorders&page=16&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T11:29:49.101Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01441492", "title": "Pancreas Resection With and Without Drains", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pancreas Tumor", "Pancreatitis" ], "interventions": [ { "name": "No Drains", "type": "PROCEDURE" }, { "name": "Drains", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 399, "start_date": "2011-09", "completion_date": "2017-07-25", "has_results": true, "last_update_posted_date": "2020-08-31", "last_synced_at": "2026-10-21T11:29:49.101Z", "location_count": 12, "location_summary": "Gainesville, Florida • Tampa, Florida • Indianapolis, Indiana + 8 more", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Mineola", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01441492" }, { "nct_id": "NCT05846971", "title": "Clinical Utility of Methylation-based Prognostic Assay for Barrett's Esophagus", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Barrett Esophagus", "Esophageal Cancer" ], "interventions": [ { "name": "Educational materials on validated methylation assay", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Capsulomics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2021-01-26", "completion_date": "2023-12-31", "has_results": false, "last_update_posted_date": "2023-05-06", "last_synced_at": "2026-10-21T11:29:49.101Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05846971" }, { "nct_id": "NCT01097044", "title": "Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Erythropoietic Protoporphyria" ], "interventions": [ { "name": "Afamelanotide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Clinuvel Pharmaceuticals Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 77, "start_date": "2010-04", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2019-10-28", "last_synced_at": "2026-10-21T11:29:49.101Z", "location_count": 6, "location_summary": "Birmingham, Alabama • San Francisco, California • New York, New York + 3 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "New York", "state": "New York" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01097044" }, { "nct_id": "NCT05369234", "title": "Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Oral Cavity Cancer", "Head and Neck Cancers - Tonsils", "Esophageal Cancer", "Laryngeal Cancer", "Oropharynx Cancer", "Mediastinal Cancer", "Chest Wall Tumor", "Radiation Mucositis" ], "interventions": [ { "name": "100% Aloe Vera Juice", "type": "DIETARY_SUPPLEMENT" }, { "name": "Magic Mouthwash", "type": "COMBINATION_PRODUCT" }, { "name": "Salt and Baking soda rinse", "type": "COMBINATION_PRODUCT" }, { "name": "Carafate", "type": "DRUG" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "COMBINATION_PRODUCT", "DRUG" ], "sponsor": "Covenant Health Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2022-01-20", "completion_date": "2024-01-30", "has_results": false, "last_update_posted_date": "2024-10-10", "last_synced_at": "2026-10-21T11:29:49.101Z", "location_count": 1, "location_summary": "Knoxville, Tennessee", "locations": [ { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT05369234" }, { "nct_id": "NCT01757964", "title": "Bacteriotherapy in Pediatric Inflammatory Bowel Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Inflammatory Bowel Disease", "Crohn's Disease", "Ulcerative Colitis", "CD" ], "interventions": [ { "name": "Bacteriotherapy", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "David Suskind", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "12 Years to 21 Years" }, "enrollment_count": 13, "start_date": "2012-12", "completion_date": "2015-01", "has_results": true, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-10-21T11:29:49.101Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01757964" }, { "nct_id": "NCT05167409", "title": "Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Microsatellite Stable Metastatic Colorectal Cancer" ], "interventions": [ { "name": "Evorpacept (ALX148)", "type": "DRUG" }, { "name": "Cetuximab", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 19, "start_date": "2022-07-28", "completion_date": "2024-10-30", "has_results": true, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-10-21T11:29:49.101Z", "location_count": 4, "location_summary": "Tucson, Arizona • Aurora, Colorado • New Brunswick, New Jersey + 1 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Aurora", "state": "Colorado" }, { "city": "New Brunswick", "state": "New Jersey" }, { "city": "Fairfax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05167409" }, { "nct_id": "NCT04095663", "title": "Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diverticulitis" ], "interventions": [ { "name": "Partial Colectomy", "type": "PROCEDURE" }, { "name": "Medical Management", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 255, "start_date": "2019-10-01", "completion_date": "2027-02-01", "has_results": false, "last_update_posted_date": "2026-02-19", "last_synced_at": "2026-10-21T11:29:49.101Z", "location_count": 29, "location_summary": "Los Angeles, California • San Diego, California • San Francisco, California + 24 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04095663" }, { "nct_id": "NCT01839487", "title": "PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Pancreatic Cancer" ], "interventions": [ { "name": "PEGPH20", "type": "DRUG" }, { "name": "Nab-paclitaxel", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Enoxaparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Halozyme Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 279, "start_date": "2013-05-14", "completion_date": "2018-09-26", "has_results": true, "last_update_posted_date": "2020-07-20", "last_synced_at": "2026-10-21T11:29:49.101Z", "location_count": 51, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Gilbert, Arizona + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01839487" }, { "nct_id": "NCT00897793", "title": "Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer", "Colorectal Cancer", "Head and Neck Cancer", "Lung Cancer", "Prostate Cancer" ], "interventions": [ { "name": "venipuncture", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "PROCEDURE", "RADIATION" ], "sponsor": "Vanderbilt-Ingram Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2006-01", "completion_date": "2010-07", "has_results": false, "last_update_posted_date": "2013-04-12", "last_synced_at": "2026-10-21T11:29:49.101Z", "location_count": 3, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00897793" }, { "nct_id": "NCT00034333", "title": "Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Carcinoma, Hepatocellular" ], "interventions": [ { "name": "MTC-DOX for Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "FeRx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 240, "start_date": "2002-03", "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-10-21T11:29:49.101Z", "location_count": 11, "location_summary": "Long Beach, California • San Francisco, California • Chicago, Illinois + 8 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New York", "state": "New York" }, { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00034333" } ] }